RD
Rohit Dinanath Karpe
About Rohit Dinanath Karpe
Data last updated:
Rohit Dinanath Karpe is a Director at De Rio Healthcare Private Limited (since 2020), Director at Regalia Pharmaceutical (India) Private Limited (since 2007) and Additional Director at Orange Chemists Private Limited (since 2018), and holds 5 more current directorships. The companies operate in Consumer Goods, Pharma and Paper. The 3 current companies with reported revenue have a combined latest revenue of ₹5.38 Cr; the largest is De Rio Healthcare Private Limited at ₹3.58 Cr (FY 2022). Earlier, Rohit Dinanath Karpe was a Director at Harinarayan Lifesciences Private Limited (2012–2015) and Director at Insaas Software Private Limited (2012–2014) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 De Rio Healthcare Private Limited U24302PN2020PTC191566 | Director | 29 Jun 2020 | 2020 | ₹3.58 Cr (FY 2022) | Active |
 Regalia Pharmaceutical (India) Private Limited U24232PN2007PTC130885 | Director | 20 Oct 2007 | 2007 | ₹98.6 Lakh (FY 2024) | Active |
| Orange Chemists Private Limited U74999PN2016PTC166602 | Additional Director | 13 Aug 2018 | 2016 | ₹81 Lakh (FY 2020) | Active |
| Spl Infusion Private Limited U21001MH2024PTC419970 | Director | 26 Feb 2024 | 2024 | Active | |
| Jsu Pharmaceutical Private Limited U46497PN2023PTC222802 | Director | 01 Aug 2023 | 2023 | Active | |
| Rohit-Pharma Distributors Private Limited U24290PN2022PTC212049 | Director | 14 Jun 2022 | 2022 | Active | |
 Regalia Life Science Private Limited U24299PN2020PTC194209 | Director | 19 Sep 2020 | 2020 | Active | |
| R. K. Hospi-Mediservices Llp AAB-1743 | Designated Partner | 19 Oct 2012 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Harinarayan Lifesciences Private Limited U74900PN2010PTC138080 | Director | 04 Aug 2012 | 2010 | ₹2 Lakh (FY 2021) | Active |
| Insaas Software Private Limited U72900PN2012PTC144788 | Director | 18 Sep 2012 | 2012 | ₹8.1 Lakh (FY 2024) | Active |
 Sys Logic Outsourcing Private Limited U74999PN2011PTC139466 | Director | 06 May 2011 | 2011 | ₹19.48 Cr (FY 2025) | Active |
| Aviras Remedies Llp AAD-5138 | Designated Partner | 25 Feb 2016 | 2015 | Strike Off | |
| Regalia Life Science Private Limited U24239PN2011PTC139705 | Director | 01 Jun 2011 | 2011 | Strike Off | |
| Reflection Imaging & Diagnostic Private Limited U33120PN2011PTC139455 | Director | 06 May 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rohit Dinanath Karpe
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sujit Dinanath Karpe | 00360612 | De Rio Healthcare Private Limited , Rohit-Pharma Distributors Private Limited and 1 more | Director |
| Anil Popatrao Belkar | 02828008 | Regalia Pharmaceutical (India) Private Limited , Jsu Pharmaceutical Private Limited and 1 more | Director |
| Ranjana Dinnath Karpe | 06708234 | Orange Chemists Private Limited | Director |
| Ashwani Anamisharan Khemka | 00337118 | Spl Infusion Private Limited | Director |
| Ishit Sandip Shah | 10474102 | Spl Infusion Private Limited | Director |
| Mrunmai Mahendra Sarvankar | 07173011 | Spl Infusion Private Limited | Director |
| Pritesh Popatlal Jain | 10176642 | Spl Infusion Private Limited | Director |
| Purva Praveen Shinde | 07875534 | Jsu Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rohit Dinanath Karpe
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rohit Dinanath Karpe
Rohit Dinanath Karpe currently holds 8 directorships: De Rio Healthcare Private Limited (Director, since 29 Jun 2020, revenue ₹3.58 Cr (FY 2022)); Regalia Pharmaceutical (India) Private Limited (Director, since 20 Oct 2007, revenue ₹98.6 Lakh (FY 2024)); Orange Chemists Private Limited (Additional Director, since 13 Aug 2018, revenue ₹81 Lakh (FY 2020)); Spl Infusion Private Limited (Director, since 26 Feb 2024); Jsu Pharmaceutical Private Limited (Director, since 01 Aug 2023); and 3 more.
Rohit Dinanath Karpe was first appointed on 20 Oct 2007 as Director at Regalia Pharmaceutical (India) Private Limited. The most recent appointment on record is 26 Feb 2024 at Spl Infusion Private Limited.
The 3 current companies of Rohit Dinanath Karpe that report revenue have a combined latest revenue of ₹5.38 Cr: De Rio Healthcare Private Limited ₹3.58 Cr (FY 2022); Regalia Pharmaceutical (India) Private Limited ₹98.6 Lakh (FY 2024); Orange Chemists Private Limited ₹81 Lakh (FY 2020).
Rohit Dinanath Karpe held 6 earlier board appointments: Harinarayan Lifesciences Private Limited (Director, 04 Aug 2012 to 22 Jan 2015); Insaas Software Private Limited (Director, 18 Sep 2012 to 08 Jan 2014); Sys Logic Outsourcing Private Limited (Director, 06 May 2011 to 18 May 2013); Aviras Remedies Llp (Designated Partner, 25 Feb 2016 to 24 Nov 2018); Regalia Life Science Private Limited (Director, from 01 Jun 2011); and 1 more.
The current boards of Rohit Dinanath Karpe's companies include Sujit Dinanath Karpe (De Rio Healthcare Private Limited), Anil Popatrao Belkar (Regalia Pharmaceutical (India) Private Limited), Ranjana Dinnath Karpe (Orange Chemists Private Limited), Ashwani Anamisharan Khemka (Spl Infusion Private Limited), Ishit Sandip Shah (Spl Infusion Private Limited), Mrunmai Mahendra Sarvankar (Spl Infusion Private Limited), among others.